Erudio Healtherudio.com
Drug
Crizotinib trials: what clinicians said in public
No HCP commentary report on a trial studying crizotinib yet. Erudio has found public clinician commentary on 10 clinical trials studying crizotinib, including ALEX, ALTA-1L, CROWN and PAPMET. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ALEX NCT02075840 · Hoffmann-La Roche DeepView → | treatment-naive advanced ALK-positive non-small-cell lung cancer | Phase 3 | Deep | View | |||
| ALTA-1L NCT02737501 · Ariad Pharmaceuticals DeepView → | ALK inhibitor-naive advanced ALK-positive non-small cell lung cancer | Phase 3 | Deep | View | |||
| PAPMET NCT02761057 · National Cancer Institute (NCI) DeepView → | advanced papillary renal cell carcinoma | Phase 2 | Deep | View | |||
| CROWN NCT03052608 · Pfizer DeepView → | Not given | Phase 3 | Deep | View | |||
| ALESIA NCT02838420 · Hoffmann-La Roche StandardView → | treatment-naive ALK-positive advanced non-small cell lung cancer | Phase 3 | Standard | View | |||
| TRUST-III NCT06564324 · Nuvation Bio Inc. StandardView → | Not given | Phase 3 | Standard | View | |||
| NCT01970865 NCT01970865 · Pfizer FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||
| NCI-NRG ALK Protocol NCT03737994 · National Cancer Institute (NCI) FocusedView → | previously treated ALK-positive stage IV non-squamous NSCLC | Phase 2 | Focused | View | |||
| NCT02767804 NCT02767804 · Xcovery Holdings, Inc. FocusedView → | Not given | Phase 3 | Focused | View | |||
| NCT04292119 NCT04292119 · Massachusetts General Hospital FocusedView → | anaplastic lymphoma kinase-rearranged lung cancer | Phase 1/Phase 2 | Focused | View | |||